awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48309941-1BA2A890-AC73-46D7-AFB1-38CF96C119EC
Q48309941-1BA2A890-AC73-46D7-AFB1-38CF96C119EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48309941-1BA2A890-AC73-46D7-AFB1-38CF96C119EC
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
P2860
Q48309941-1BA2A890-AC73-46D7-AFB1-38CF96C119EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48309941-1BA2A890-AC73-46D7-AFB1-38CF96C119EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd01e6c4360df59814ff4520df296c31fd6c9761
P2860
A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)